A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer. - Zamulko O; Nusbaum S; Osterburg A; Crist M; Lehn M; Monroe I; Romano A; Allen CL; Forsythe A; Riaz MK; Lemmon C; Takiar V; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)